Penile prosthesis implantation is recognized as a valid option to obtain an artificial erection satisfactory for sexual intercourse in those patients in which a pharmacological approach is contraindicated or ineffective. Penile prostheses are subbject to continuous development and they are achieving ever better mechanical reliability and safety. The devices are divided into two general types: semirigid (malleable and mechanical) and inflatables. The AMS Õ (American Medical Systems) and Coloplast Ltd Õ produce the majority of inflatable and semirigid devices.
Introduction
Erectile dysfunction (ED) is a condition that affects more than half of men between 40 and 70 years of age. Pharmacological therapy for ED has improved dramatically in the last 10 years and today the oral phosphodiesterase type-5 inhibitors are the most commonly used and successful treatments in first-line therapy. Intracavernous vasodilator injection therapy is a second-line treatment used to treat those cases where a mild-to-severe arteriogenic or veno-occlusive dysfunction is present with a consequent ineffectiveness of oral drugs. In patients where pharmacological therapy is unhelpful or contraindicated, another option is the surgical approach. Penile vascular surgery is suitable only for healthy men with acquired ED due to isolated stenosis of extrapenile arteries without any kind of generalized vascular disease [Montague et al. 2005] .
Penile prosthesis implant is recognized, at present, as the most effective option to obtain an artificial erection satisfactory for a sexual intercourse in those patients in which the pharmacological approach is contraindicated or ineffective. These devices are subject to continuous development and they are achieving even better mechanical reliability and safety. Patient satisfaction with the cosmetic appearance and the widespread use of prostheses reflect their quality and the experience gained by surgeons in device implantation.
Patient selection
Penile prosthesis surgery represents the 'gold standard' in those patients in which ED has reached an end-stage and oral and intracavernous pharmacological therapies are ineffective, contraindicated or cannot be tolerated. This is the case, for example, in severe arteriogenic and venoocclusive dysfunction caused by severe systemic disease such as diabetes, hypertensive arterial syndrome, neurological disorders and related treatment [Hatzimouratidis and Hatzichristou, 2004] . Non nerve-sparing pelvic surgery performed on the bladder, prostate and rectum is another major cause of ED because of the interruption of the neurovascular bundles involved in erectile mechanisms [Meuleman and Mulders, 2003 ]. Penile prosthesis implants may also be used to obtain rigidity in cases of phalloplasty performed for gender dysphoria [Bettocchi et al. 2004] , after radical surgery for penile cancer and for treatment of congenital or acquired missing penis [Hoebeke et al. 2003; Jordan et al. 1994 ].
The first step in the implantation of a penile prosthesis is correct informed consent, to be discussed with the patient and his partner in order to understand their expectations of this treatment, and dispel any unrealistic ones. The patient must know that the device positioning causes destruction of the corpora cavernosa and for this reason it has to be considered an irreversible procedure which ends any degree of spontaneous erection after surgery.
The surgeon should present the several devices available on the market, according to the requirements of the patient. This phase is critical: handling a prosthetic sample and understanding its function is useful in order to allow an easy and quick start of the use of the prosthesis after surgery. An important aspect to be stressed is the high level of satisfaction expressed by those patients who have already undergone this kind of treatment, which is up to 97% of cases [Bettocchi et al. 2010; Natali et al. 2008] . In spite of this degree of satisfaction the patient should know that the implant of a penile prosthesis is burdened by the possibility of infection (3%), erosion (1%) and mechanical malfunction of the device (12%) and these complications may possibly require removal of the prosthesis and subsequent repositioning [Carson et al. 2000 ].
The implant is contraindicated in case of recurrent urinary infection and in those situations which could increase the risk of local infections such as spinal cord injury, poorly controlled diabetes and immunosuppressive therapies. Patients with low motivation or the wrong expectations should not undergo penile prosthesis implant.
Penile prosthesis selection
In 1973 the first device designed to allow artificial erectile tumescence was introduced to the market. It was the ScottBradleyTimm inflatable prosthesis composed of two intracorporeal silicone cylinders, a scrotal activator and an abdominal reservoir filled with saline solution. This kind of device, comparable to the modern three-piece prosthesis, was characterized by a mechanical failure in 2145% of cases. In 1980 Jonas and Jacobi introduced the first malleable prosthesis composed of two silicone cylinders with a twisted wire core which allowed sufficient rigidity for sexual intercourse [Simmons and Montague, 2008] .
Penile prostheses currently available have achieved better safety and reliability, and for this reason the percentage of malfunctions and complications has appreciably decreased. The devices are divided into two general groups: semirigid (malleable and mechanical) and inflatables. AMS Õ (American Medical Systems, Minnetonka, Minnesota, USA) and Coloplast Ltd Õ (Peterborough, Cambs, England) produce the majority of inflatable and semirigid devices (Table 1) . Rigidity is achieved by all these kind of devices but the differences lie in the cosmetic result and in the possibility of obtaining a natural-like flaccidity.
Semirigid devices
Malleable and mechanical prostheses have the disadvantage that the penis is always erect but it can be orientated in different ways depending on the need to have sexual intercourse, to urinate or to conceal it with clothes. The advantages are ease of use and the simpler surgical procedure needed compared to inflatable prostheses [Atienza Merino, 2006 ]. Malleable prostheses available on market are the AMS 600 TM and the AMS 650 TM by AMS Õ and the Genesis TM by Coloplast Ltd Õ (previously marketed under the name Mentor Acu-Form TM by Mentor Corporation). Other malleable devices are the Promedon-Tube Õ (Cordoba, Argentina), the Silimed Õ prosthesis (Rio de Janeiro, RJ, Brazil) and the Jonas Õ prosthesis by Bard Co. (Murray Hill, New Jersey, USA). These kinds of devices are characterized by two silicone cylinders and an internal twisted stainless steel wire core.
A particular kind of malleable prosthesis are the Virilis I TM and Virilis II TM prostheses by Giant Medical (Cremona, Italy). The feature of these implants is the absence of a silver core and the fact that they are a completely soft prosthesis made of silicone. In this case, the erectile tissue can be displaced and not destroyed in implant positioning and erection can be reached thanks to the Subrini concept [Subrini, 1994] . According to this, the device assures a reduction in the venous bed and in the quota of tissue to be expanded by a reduced arterial flow ensuring support to the physiological erection.
The Apollo TM prosthesis (Giant Medical Corporation, Cremona, Italy) is a device designed to be filled periodically with saline solution in order to obtain tissue expansion. It represents a temporary device eligible for use when it is necessary to increase the length of the corpora before implantation of the definitive prosthesis [Simmons and Montague, 2008] .
AMS Õ produce the Dura II TM mechanical prosthesis and it differs from the previous ones because it can be better concealed thanks to the ability to remain flat when pushed downward. This feature is enabled by an internal series of polyethylene disks articulated with a metal cable that runs through the centre of the disks and fastens with a spring to each end of a cylinder made of polytetrafluoroethylene and silicone [Kearse et al. 1996 ].
Inflatable devices
Modern inflatable prostheses may have two or three components. Two-component prostheses are composed of two flexible cylinders inserted into the corpora cavernosa, and a reservoir placed at the end of each cylinder connected to a pump inserted into the scrotum. A twocomponent prosthesis available on market is the AMS Ambicor Õ .
Three-component prostheses are more sophisticated devices and consist of two cylinders that are implanted into the corpora cavernosa, a pump which is placed in the scrotum and is connected with a reservoir filled with saline solution and inserted into the Retzius space or into the peritoneum [Woodworth et al. 1991] . The advantages of these devices are that they feel softer than semirigid or two-piece devices when deflated, with a better cosmetic result, and they ensure a more natural erection than other kinds of prosthesis. The disadvantages are the possibility of malfunction and by the need for a more complicated surgical technique. AMS Õ produce the 700 TM series composed of three different models: AMS 700 CX TM (controlled expansion cylinders); AMS 700 Ultrex TM , composed of a bi-woven fabric which allows controlled expansion in girth and length with up to 20% length expansion; and AMS CXR TM which is the optimal choice in cases of fibrosis of corpora cavernosa, scarred corporal bodies and stenotic proximal corpora, thanks to its reduced profile. These devices are now available with Inhibizone TM , an external layer made with a combination of minocyclin and rifampin in order to prevent bacterial colonization. AMS Õ introduced the Tactile pump for the 700 TM series in 2004 which has been designed to make inflation easier thanks to a larger volume of fluid transferred into the cylinders at each squeeze and to offer the possibility of better localization thanks to its sharper surface. Coloplast Ltd Õ produces several three-piece prostheses: the In order to make deflation easier AMS Õ and Coloplast Ltd Õ introduced the 'Momentary Squeeze' and 'One-touch Release' valves in 2006 and 2008 respectively. The MS valve (Momentary Squeeze) allows the user to press the button once and then squeeze the cylinders, without doing it simultaneously. This kind of activator is smaller than previous models and it is characterized by a lockout valve to prevent auto-inflation. Coloplast Ltd Õ introduced the Titan TM OTR (One-Touch Release) which has the same deflation and auto-inflation prevention features.
Surgical technique
The implantation of a penile prosthesis can be performed in a short surgical time under locoregional spinal anaesthesia. Hospitalization is usually brief and the patient can be discharged 1 or 2 days after the operation if complications are not evident.
The first step in the prosthetic surgery is a careful and 10-minute long hibiscrub bath of the operative field to prevent the risk of infection. Better sterility can be achieved with a limited number of personnel in theatre and changing gloves/drapes before the handling the prosthesis.
There are different surgical approaches to implanting a penile prosthesis and they depend on the device to be positioned and the surgeon's experience. Subcoronal incision is suitable when a malleable or a mechanical prosthesis is implanted, while penoscrotal or infrapubic approaches are chosen for inflatable devices. In the first case, the distal corpora are incised proximally to the glans and dilated along the entire length of the shaft using different sizes of dilators. The corpora are measured in order to choose the correct size of prosthesis, the cylinders are inserted and the corpora sutured with absorbable stitches [Evans, 2001] .
A 10 cm infrapubic incision is performed transversely across the pubic symphysis in order to reach the corpora below the pubic bone.
The need to insert the activator in the scrotum and the reservoir in the Retzius space in case of a three-piece prosthesis requires a bigger incision.
In the penoscrotal incision the corpora are isolated from the urethra, incised longitudinally, dilated and measured. The 65 ml or 100 ml reservoir is inserted laterally to the bladder across a breach performed medially to the external inguinal ring. During this phase, in order to avoid bladder lesions, the surgeon empties the bladder using a previously placed Foley catheter. The cylinders and the activator are inserted and connected to the reservoir [Evans, 2001] .
Regardless the kind of incision performed, the operative field must be irrigated with antibiotic solution before implanting the device. The inflatable prosthesis has to be tested to exclude mechanical damage. A careful haemostasis is performed and a drain can be inserted if necessary in order to prevent haematoma. The Foley catheter and the drain can be removed on the first day after surgery if contraindications are not present.
Follow up
The first postoperative check is performed 2 weeks after discharge to control the wound and the device functioning. This period is critical to recognize early any signs or symptoms of local infection and treat it. The surgeon will teach the patient how to use the prosthesis 4 weeks after surgery, but usually the patient will start to use it 6 weeks after implantation. At 3-month and then yearly intervals an examination is scheduled to check the wound, the correct functioning of the device and the degree of patient and partner satisfaction.
Outcomes
Penile prostheses implants represent a valid therapeutic option to achieve satisfactory sexual intercourse in those patients where other approaches have failed. Patient and partner satisfaction is achieved in almost all couples who have chosen this kind of solution. Goldstein et al. in 1997 reported fulfilled expectation in 89% of patients who underwent inflatable prosthesis implantation. In recent literature this percentage is up to 97% [Bettocchi et al. 2010; Natali et al. 2008] .
Even if the results are positive, in the vast majority of patients the possibility of several complications makes penile prosthesis implantation a delicate kind of surgery. Complications can Therapeutic Advances in Urology 2 (1) happen when the operation is carried out, in the peri-operative and in the postoperative period.
During the operation the most important complications can involve the urethra, the bladder and intestine. Urethral injuries may occur during the dilatation of the corpora cavernosa and can especially affect scarred tissues. Bladder and visceral injuries can happen during the positioning of the reservoir with the penoscrotal incision, due to the blindness of this procedure. The opening of the fascia to have access to the Retzius space is a delicate phase because the peritoneum and the bladder can be perforated. Any kinds of injuries must be checked by a laparotomic exploration or a cystoscopy and treated [Bettocchi et al. 2008 ].
Breakage or mechanical failure of the device are complications which may be checked before the implant procedure. Any kind of injury to the prosthesis can be easily avoided by putting sutures on the corpora before the placement of the cylinders, while correct functioning should be tested before the end of the operation in order to allow substitution at this stage.
Infection (ranges from 1.7% to 15%) [Minervini et al. 2005; Govier et al. 1998 ] is an important complication which could cause the revision or the removal of the device. Infections are generally caused by Staphylococcus epidermidis and S. aureus, followed by Gram-negative bacteria, S. aureus and anaerobic organisms [Evans, 2001] . Clinically it is characterized by fever, persistent scrotal pain, erythema and evidence of purulent material from the wound. Systemic antibiotic therapy is not sufficient to treat this complication; the removal of the prosthesis is recommended either with immediate replacement or replacement after some months [Bettocchi et al. 2008] . The importance of this aspect is stressed by the introduction of the InhibiZone TM prostheses by AMS Õ and Titan TM prostheses by Coloplast Ltd Õ , conceived to inhibit bacterial adhesion and proliferation with a proven reduction in infection rates from 2% to 1.06% [Carson et al. 2000 ].
Mechanical disorders of the prosthesis (ranging from 1.4% to 13.7%) [Minervini et al. 2005; Govier et al. 1998 ] are becoming less common thanks to improvement of the devices. The most common complications are fluid loss, cylinder rupture and mechanical breakage, and require removal of the prostheses [Carson et al. 2000 ]. Auto-inflation (ranging from 2.4% to 11%) [Wilson et al. 2002; Carson et al. 2000 ] is a mechanical disorder which can happen in the implanted prosthesis. In order to avoid this kind of complication Coloplast Ltd Õ and AMS Õ introduced antireflux 'lock-out' valves with a consequent reduction of auto-inflation to 1.3% [Wilson et al. 2002] .
Conclusions
Penile prosthesis implantation is a therapeutic option suitable for those patients in whom a pharmacological approach is contraindicated or ineffective. This kind of surgery is relatively easy compared with other urological procedures and surgeons' experience has improved remarkably. Penile prostheses are subject to continuous development and they are achieving even better mechanical reliability and safety. Patient and partner satisfaction reflect the quality and the effectiveness of this treatment.
